©The Author(s) 2025.
World J Clin Oncol. Nov 24, 2025; 16(11): 111419
Published online Nov 24, 2025. doi: 10.5306/wjco.v16.i11.111419
Published online Nov 24, 2025. doi: 10.5306/wjco.v16.i11.111419
Table 1 Microbiota-targeted interventions in pediatric leukemia
| Intervention | Agent | Clinical implications | Ref. |
| Probiotics | Lactobacillus rhamnosus GG | Reduced gastrointestinal toxicity; reduced antibiotic use | Martyniak et al[20], 2023 |
| Probiotics | Bifidobacterium breve Yakult | Fewer fever episodes; reduced pathogens | Todor and Ichim[8], 2025 |
| Prebiotics | Inulin | Increased chemo efficacy; reduced complications | Martyniak et al[20], 2023 |
| Prebiotics | Pectin | Protects gut barrier during chemo | Martyniak et al[20], 2023 |
| Postbiotics | Butyrate | Anti-inflammatory; anti-leukemic | Martyniak et al[20], 2023 |
| Synbiotics | LactoCare (multi-strain + prebiotic) | 96% reduced diarrhea | Martyniak et al[20], 2023 |
| FMT | Fresh/frozen FMT | 86% response in steroid-refractory GvHD | Todor and Ichim[8], 2025 |
| Nutrition | Enteral nutrition | Better hematopoietic stem cell transplantation outcomes; reduced GvHD | Muratore et al[19], 2022 |
- Citation: Roganovic J, Radosevic M, Dordevic A. Role of the gut microbiome in the development and prognosis of pediatric leukemia. World J Clin Oncol 2025; 16(11): 111419
- URL: https://www.wjgnet.com/2218-4333/full/v16/i11/111419.htm
- DOI: https://dx.doi.org/10.5306/wjco.v16.i11.111419